Published Resources
Scientists identify brain cells linked to depression
Scientists at McGill University and the Douglas Institute have discovered that two distinct types of brain cells show changes in people experiencing depression. Published in Nature Genetics, the research provides new clues that could guide the creation of treatments focused on these specific cells. It also enhances scientific understanding of depression, a condition that affects more […]
Read MoreDiet Impact on the Brain
A new study from UNC School of Medicine researchers, published in Neuron, reveals a unique look at how junk food rewires the brain’s memory hub – leading to risk of cognitive dysfunction. This new research opens the door to early interventions that can prevent even long-term memory loss associated with obesity. Led by UNC School of Medicine’s […]
Read MoreExperts: Smartphones before 13 could harm mental health
Getting a smartphone before age 13 may drastically increase the risk of poor mental health later in life, according to data from more than 100,000 people. Early use is linked to suicidal thoughts, aggression, and detachment, largely driven by social media, cyberbullying, and lost sleep. Researchers urge urgent action to restrict access and protect young […]
Read MoreScience tested 64 natural remedies for depression – only a few actually work
Most people have heard of St John’s Wort and omega-3s. But did you know there are a lot more over-the-counter herbal products and supplements out there targeting depression?In our review of clinical trials of these products, we found 64 different over-the-counter (OTC) products that have been evaluated for depression – but with differing levels of […]
Read MoreAccess to Clozapine for Treatment-Resistant Schizophrenia Expanded
FDA has just made it easier for patients to get clozapine, the only drug approved for treatment-resistant schizophrenia. The agency has removed a long-standing requirement for patients to submit lab test results showing healthy levels of white blood cells known as neutrophils in order to receive prescriptions for clozapine. The requirement was originally put in place […]
Read MoreFDA Approves Auvelity, a New Medication for Clinical Depression
The U.S. Food and Drug Administration in August 2022 approved dextromethorphan-bupropion, or Auvelity, a drug used to treat major depressive disorder, also known as clinical depression, in adults. It is the first drug to treat major depressive disorder that works within a week of taking it and is the first new pill to treat depression […]
Read MoreResearch – What causes anxiety disorders and anxiety?
The exact causes of anxiety disorders are unknown. According to the National Institute of Mental Health (NIMH)Trusted Source, a combination of genetic and environmental factors may play a role. Brain chemistry is also being studied as a possible cause. The areas of your brain that control your fear response may be involved. Anxiety disorders often […]
Read MoreAdvances in Treatment for Major Depressive Disorder
Major depressive disorder is the most widespread mood disorder in the world. Also called clinical depression, or just depression, it’s when you have symptoms of low mood or hopelessness for at least 2 weeks. Scientists still don’t know what causes it. But they know that treating it is complex and that people who have it […]
Read More